News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Mid-career researcher recognised by the Victorian Cancer Agency
Congratulations to Dr Daniel Gough for receiving a Mid-Career Research Fellowship from the Victorian Cancer Agency (VCA) for his research in developing new therapies for small cell lung cancer (SCLC).… Read more
-
Protecting growth-restricted babies from brain injury with stem cell therapy
Hudson Institute scientists have demonstrated for the first time that umbilical cord stem cells can protect preterm, growth-restricted babies from brain injury.… Read more
-
Presentation of the inaugural Daniel Wilson Metafit PhD Scholarship
We are pleased to announce that the inaugural recipient of the Daniel Wilson Memorial PhD Scholarship is Alice West—who, thanks to tremendous fundraising efforts, will have her research costs fully covered over the entirety of her 3–4-year study in stomach cancer.… Read more
-
Stem cells help premature babies with lung disease
Hudson Institute and Monash University researchers have assessed the long-term outcomes of their world-first study that used placental stem cells in premature babies with severe bronchopulmonary dysplasia, a form of chronic lung disease.… Read more
-
Safer surgery for babies with open spina bifida
A team of researchers at Hudson Institute have discovered how to make in utero surgery safer for babies with open spina bifida, by using warm, moist air to distend a mother’s uterus.… Read more
-
Shedding light on the male bias in childhood brain tumours
Hudson Institute researchers discover why the most common form of childhood brain cancer is seen in boys more than girls, and identify a potential biomarker for less aggressive treatment.… Read more
-
Advanced imaging tips T cell target recognition on its head
A team of leading Australian scientists have published research which transforms existing perceptions of T cell recognition.… Read more
-
Promising target against Australia’s second deadliest cancer
Hudson Institute researchers have identified a target for controlling the development of colon cancer that could lead to novel treatment strategies.… Read more
-
Contraception—a non-hormonal alternative
Hudson Institute researchers have discovered that inhibiting a protein called SOX17 prevents an embryo mimic from ‘sticking’ to the uterus lining—highlighting potential for a new contraceptive strategy… Read more
-
Gut feeling leads to major NHMRC grant to investigate immunity
New and improved treatments for many serious ailments could follow a prestigious $5 million NHMRC Synergy grant to a team led by Hudson Institute of Medical Research scientists.… Read more